Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid - PubMed (original) (raw)
Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid
D L Segev et al. J Clin Endocrinol Metab. 1998 Jun.
Abstract
Follicular and Hürthle cell carcinomas of the thyroid cannot be differentiated from adenomas by either preoperative fine needle aspiration or intraoperative frozen section examination, and yet there exist potentially significant differences in the recommended surgical management. We examined, by PCR-based microsatellite polymorphism analysis, DNA obtained from 83 thyroid neoplasms [22 follicular adenomas, 29 follicular carcinomas, 20 Hürthle cell adenomas (HA), and 12 Hürthle cell carcinomas (HC)] to determine whether a pattern of allelic alteration exists that could help distinguish benign from malignant lesions. Alterations were found in only 7.5% of informative PCR reactions from follicular neoplasms, whereas they were found in 23.3% of reactions from Hürthle cell neoplasms. Although there were no significant differences between follicular adenoma and follicular carcinoma, HC demonstrated a significantly greater percentage of allelic alteration than HA on chromosomal arms 1q (P < 0.001) and 2p (P < 0.05) by Fisher's exact test. The documentation of an alteration on either 1q or 2p was 100% sensitive and 65% specific in the detection of HC (P < 0.0005, by McNemar's test). In conclusion, PCR-based microsatellite polymorphism analysis may be a useful technique in distinguishing HC from HA. Potentially, the application of this technique to aspirated material may allow this distinction preoperatively and thus facilitate more optimal surgical management. Consistent regions of allelic alteration may also indicate the locations of critical genes, such as tumor suppressor genes or oncogenes, that are important in the progression from adenoma to carcinoma. Finally, this study demonstrates that Hürthle cell neoplasms, now considered variants of follicular neoplasms, differ significantly from follicular neoplasms on a molecular level.
Similar articles
- Polymerase chain reaction-based microsatellite analysis of fine-needle aspirations from Hürthle cell neoplasms.
Takiyama Y, Saji M, Clark DP, Phillips GS, Segev DL, Smallridge RC, Westra WH, Udelsman R, Zeiger MA. Takiyama Y, et al. Thyroid. 1997 Dec;7(6):853-7. doi: 10.1089/thy.1997.7.853. Thyroid. 1997. PMID: 9459628 - Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.
Sugishita Y, Kammori M, Yamada O, Yamazaki K, Ito K, Fukumori T, Yoshikawa K, Yamada T. Sugishita Y, et al. Ann Surg Oncol. 2014 Jul;21(7):2318-25. doi: 10.1245/s10434-014-3552-6. Epub 2014 Feb 22. Ann Surg Oncol. 2014. PMID: 24562933 - Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
Máximo V, Preto A, Crespo A, Rocha AS, Machado JC, Soares P, Sobrinho-Simões M. Máximo V, et al. BMC Cancer. 2004 Mar 25;4:12. doi: 10.1186/1471-2407-4-12. BMC Cancer. 2004. PMID: 15043758 Free PMC article. - Management of follicular and Hürthle cell neoplasms of the thyroid gland.
McHenry CR, Sandoval BA. McHenry CR, et al. Surg Oncol Clin N Am. 1998 Oct;7(4):893-910. Surg Oncol Clin N Am. 1998. PMID: 9735140 Review. - Molecular pathogenesis of follicular cell derived thyroid cancers.
Parameswaran R, Brooks S, Sadler GP. Parameswaran R, et al. Int J Surg. 2010;8(3):186-93. doi: 10.1016/j.ijsu.2010.01.005. Epub 2010 Jan 25. Int J Surg. 2010. PMID: 20097316 Review.
Cited by
- DNA FISH Diagnostic Assay on Cytological Samples of Thyroid Follicular Neoplasms.
Vielh P, Balogh Z, Suciu V, Richon C, Job B, Meurice G, Valent A, Lacroix L, Marty V, Motte N, Dessen P, Caillou B, Ghuzlan AA, Bidart JM, Lazar V, Hofman P, Scoazec JY, El-Naggar AK, Schlumberger M. Vielh P, et al. Cancers (Basel). 2020 Sep 6;12(9):2529. doi: 10.3390/cancers12092529. Cancers (Basel). 2020. PMID: 32899953 Free PMC article. - Oncocytic mania: a review of oncocytic lesions throughout the body.
Guaraldi F, Zang G, Dackiw AP, Caturegli P. Guaraldi F, et al. J Endocrinol Invest. 2011 May;34(5):383-94. doi: 10.1007/BF03347464. Epub 2011 Feb 7. J Endocrinol Invest. 2011. PMID: 21301204 Review. - Thyroid cancer: current molecular perspectives.
Giusti F, Falchetti A, Franceschelli F, Marini F, Tanini A, Brandi ML. Giusti F, et al. J Oncol. 2010;2010:351679. doi: 10.1155/2010/351679. Epub 2010 Mar 29. J Oncol. 2010. PMID: 20369062 Free PMC article. - Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer.
McKay JD, Thompson D, Lesueur F, Stankov K, Pastore A, Watfah C, Strolz S, Riccabona G, Moncayo R, Romeo G, Goldgar DE. McKay JD, et al. J Med Genet. 2004 Jun;41(6):407-12. doi: 10.1136/jmg.2003.017350. J Med Genet. 2004. PMID: 15173224 Free PMC article. - Genetic and biological subgroups of low-stage follicular thyroid cancer.
French CA, Alexander EK, Cibas ES, Nose V, Laguette J, Faquin W, Garber J, Moore F Jr, Fletcher JA, Larsen PR, Kroll TG. French CA, et al. Am J Pathol. 2003 Apr;162(4):1053-60. doi: 10.1016/S0002-9440(10)63902-8. Am J Pathol. 2003. PMID: 12651598 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical